https://scholars.lib.ntu.edu.tw/handle/123456789/578639
標題: | Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients | 作者: | YU-SHAN HUANG Cheng C.-Y. Liou B.-H. Lu P.-L. Cheng S.-H. Lee Y.-T. Liu C.-E. HSIN-YUN SUN Yang C.-J. Tang H.-J. Lin S.-P. Ho M.-W. Huang S.-H. Tsai H.-C. Lee C.-H. CHIEN-CHING HUNG Taiwan HIV Study Group |
公開日期: | 2021 | 出版社: | NLM (Medline) | 卷: | 86 | 期: | 4 | 起(迄)頁: | 473-481 | 來源出版物: | Journal of acquired immune deficiency syndromes (1999) | 摘要: | BACKGROUND: The efficacy and safety of switching from tenofovir disoproxil fumarate-based antiretroviral therapy to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (E/C/F/TAF) has not been widely investigated in HIV/hepatit |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102221589&doi=10.1097%2fQAI.0000000000002589&partnerID=40&md5=82faf108c7700ebd0c91fa75d7dbce2b https://scholars.lib.ntu.edu.tw/handle/123456789/578639 |
ISSN: | 1944-7884 | DOI: | 10.1097/QAI.0000000000002589 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。